Influence of tobacco on the labelling of red blood cells and plasma proteins with Technetium-99m

Journal of Experimental and Clinical Cancer Research

Volumn 17, Issue 1, 1998, Pages 41-46

  Vidal, M V ^a   Gutfilen, B ^a,b   Barbosa Da Fonseca, L M ^b,c   Bernardo Filho, M ^a,c  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

Plasma proteins; Reactive oxygen species; Red blood cells; Stannous ion; Technetium 99m; Tobacco

Indexed keywords

TECHNETIUM 99M;

ARTICLE; CANCER RESEARCH; CHEMICAL CARCINOGENESIS; ERYTHROCYTE; HUMAN; HUMAN CELL; ISOTOPE LABELING; LARYNX CANCER; MOUTH CANCER; PHARYNX CANCER; PRIORITY JOURNAL; SMOKING; TOBACCO;

ANIMALS; BLOOD PROTEINS; DEPRESSION, CHEMICAL; ERYTHROCYTES; ISOTOPE LABELING; PLANT EXTRACTS; PLANTS, TOXIC; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; TECHNETIUM; TIN; TOBACCO;

EID: 0031967012     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Perkins A.C., Frier M.: Nuclear medicine techniques in the evaluation of pharmaceutical formulations. Pharm World Sci 18: 97-104, 1996.
2. Srivastava S.: State of the art (and science) of blood cell labeling. Brookhaven Lecture Series 232: 1-14, 1987.
3. Harbert J.C., Eckelman W.C., Neumann R.D.: Nuclear Medicine Diagnosis and Therapy. Thieme Medical Publishers, Inc., New York, 1996, 1256.
4. Fisher J., Wolf R., Leon A.: Technetium-99m as a label for erythrocytes. J Nucl Med 8: 228-232, 1967.
5. Early P.J., Soddee D.B.: Principles and Practice of Nuclear Medicine. Mosby - Year Book, Inc., Toronto, 1995, 877.
6. Hladik III W.B., Saha G.B., Study K.T.: Essentials of Nuclear Medicine Sciences. William and Wilkins, Sydney, 1987, 439.
7. Saha G.B.:. Fundamentals of Nuclear Pharmacy. Springer-Verlag, New York, 1992, 357.
8. Bernardo-Filho M., Nogueira J.F., Sturm J.A., Boasquevisque E.M.: Plasma proteins labeling with 99mtechnetium. Arq Biol Tecnol 33: 811-817, 1990.
9. Santos J.S., Paula E.F., Correa T.G., Freitas L.C., Fonseca L.M., Gutfilen B., Bernardo-Filho M.: Effect of cyclophosphamide on the binding of 99mTcO4- and 99mTc-MDP to blood cells and plasma proteins. Braz J Med Biol Res 28: 131-135, 1995.
10. Ripoll-Hamer E., Freitas L.C., Paula E.F., Fonseca L.M., Gutfilen B., Bernardo-Filho M.: In vitro effect of cyclophosphamide on the binding of radiopharmaceuticals (99mTcO4- and 99mTc-MDP) to blood elements. Braz J Med Biol Res 28: 256-260, 1995.
11. Vanlic-Razumenic N., Petrovic J., Gorkic D.: Biochemical studies of the renal radiopharmaceutical compound dimercaptosuccinate. IV. Interaction of 99mTc-DMS and 99mTc-DMS complexes with blood serum proteins. Eur J Nucl Med 9: 370-373, 1984.
12. Vanlic-Razumenic N., Joksimovic J., Ristic B., Tomic M., Beatovc S., Ajdinovic B.: Interaction of 99mTc-radiopharmaceuticals with transport proteins in human blood. Nucl Med Biol 20: 363-365, 1993.
13. Vanlic-Razumenic N., Petrovic J., Gorkic D.: Binding of Tc-99m-MDP complex by human serum constituents. J Labeled Compds Radiopharm 19: 1568-1569, 1982.
14. Ligny C.L., Gelsema W.J., Tji T.G., Huigen Y.M., Vink H.A.: Bone seeking radiopharmaceuticals. Nucl Med Biol 17: 161-179, 1990.
15. Hesselewood S., Leung E.: Drug interactions with radiopharmaceuticals. Eur J Nucl Med 21: 348-356, 1994.
16. Calabresi P., Schein P.S.: Medical Oncology, Basic Principles and Clinical Management of Cancer, McGraw-Hill, INC, Health Professions Division, New York, 1993, 1352.
17. Porter W.C., Dees S.M., Freitas J.E. and Dworkin H.D.: Acid-citrate-dextrose compared with heparin in the preparation in vivo/in vitro technetium-99m red blood cells. J Nucl Med 24: 383-387, 1983.
18. Bernardo-Filho M., Gutfilen B., Maciel O.S.: Effect of different anticoagulants on the labelling of red blood cells and plasma proteins with Tc-99m. Nucl Med Comm 15: 730-734, 1994.
19. Srivastava S.C., Straub R.F., Richards P.: Mechanistic aspects of the technetium-99m-tin-RBC labeling reactions. J Labeled Compds Radiopharm 21: 1055, 1984.
20. Srivastava S.C. and Straub R.F.: Evaluation of heparin and anticoagulant citrate dextrose in the preparation of technetium-99m-red blood cell with Ultra Tag RBC kit. J Nucl Med 33: 307-308, 1992.
21. Gilman A.G., Goodman L.S., Kall T.W., Murad F.: The Pharmacological Basis of Therapeutics. 8th Edition. Pergamon Press, Inc., Macmillan Publishing Company, 1990, 1232.
22. Iskander F.Y., Bauer T.L., Klein D.E.: Determination of 28 elements in american cigarette tobacco by neutron-activation analysis. Analyst 111: 107-109, 1986.
23. Gutfilen B., Boasquevisque E.M., Bernardo-Filho M.: Calcium channel blockers: Interference on red blood cell and plasma protein labeling with Tc-99m. Rev Esp Med Nucl 11: 195-199, 1993.
24. Bernardo-Filho M., Gutfilen B., Souza J.E.Q., Maciel O.S., Boasquevisque E.M., Gabbay S., Martinho M.J.R., Hasson-Voloch A.: Labeling of red blood cells with 99mtechnetium: A very simple kit. Acta Med Biol 40: 129-131, 1992.
25. Bernardo-Filho M., Gutfilen B., Canine M., Boasquevisque E.M., Hasson-Voloch A. Selective splenic scintigraphy: A very simple technique. Acta Med Biol 40: 133-136, 1992.
26. Sampson C.B.: Complications and difficulties in radiolabelling blood cells: A review. Nucl Med Comm 17: 648-658, 1996.
27. Halliwell B., Aruoma O.I.: DNA and free radicals. Ellis Horwood. New York, 1993.
28. Ames B.N.:. Dietary carcinogens and anticarcinogens: oxygen radicals and degenerative diseases. Science 221: 1256-1264, 1983.
29. Church D.F., Pryor W.A.: Free-radical chemistry of cigarette smoke and its toxicological implications. Environmental Health Perspectives 64: 111-126, 1985.
30. Pryor W.A.: Cigarette smoke and the involvement of free radical reactions in chemical carcinogenesis. Brit J Cancer 55: 19-23, 1987.
31. Moldéus P., Berggren M., Gravström R.: N-acetylcysteine protection against the toxicity of cigarette smoke and cigarette condensate in various tissues and cells in vitro. Eur J Respiratory Disease 139: 123-129, 1985.
32. Hunninghake G.W., Gadek J., Chrystal R.: Mechanism by which cigarette smoke attracts polymorphonuclear leukocytes to lung. Chest 77:273, 1980.